Elze Christian bought PLX
September 3, 2026 · Form 4 insider transaction
Elze Christian bought 17,000 shares of Protalix BioTherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
17,000
Price
$0.00
Total value
N/A
InsiderElze Christian
RoleDirector
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 3, 2026
Filing dateSeptember 4, 2026
Shares owned after17,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.; Does not include options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.